Greetje J Tack

Summary

Affiliation: VU University Medical Center
Country: The Netherlands

Publications

  1. ncbi Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study
    Greetje J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Centre, PO Box 7057, Amsterdam 1007 MB, The Netherlands
    BMC Gastroenterol 12:159. 2012
  2. ncbi Tioguanine in the treatment of refractory coeliac disease--a single centre experience
    G J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands
    Aliment Pharmacol Ther 36:274-81. 2012
  3. ncbi Origin and immunophenotype of aberrant IEL in RCDII patients
    Greetje J Tack
    Gastroenterology and Hepatology, VU University Medical Center, The Netherlands
    Mol Immunol 50:262-70. 2012
  4. ncbi The spectrum of celiac disease: epidemiology, clinical aspects and treatment
    Greetje J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
    Nat Rev Gastroenterol Hepatol 7:204-13. 2010
  5. ncbi Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy
    G J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands
    Bone Marrow Transplant 46:840-6. 2011
  6. ncbi Evaluation of Cladribine treatment in refractory celiac disease type II
    Greetje J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands
    World J Gastroenterol 17:506-13. 2011

Detail Information

Publications6

  1. ncbi Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study
    Greetje J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Centre, PO Box 7057, Amsterdam 1007 MB, The Netherlands
    BMC Gastroenterol 12:159. 2012
    ..Invasive techniques are still required to distinguish between uncomplicated and complicated forms of CD...
  2. ncbi Tioguanine in the treatment of refractory coeliac disease--a single centre experience
    G J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands
    Aliment Pharmacol Ther 36:274-81. 2012
    ..Besides corticosteroids, azathioprine has been advocated for the treatment of refractory coeliac disease type I. However, tioguanine (TG) might be better tolerated and more efficacious owing to a simpler metabolism towards bioactivation...
  3. ncbi Origin and immunophenotype of aberrant IEL in RCDII patients
    Greetje J Tack
    Gastroenterology and Hepatology, VU University Medical Center, The Netherlands
    Mol Immunol 50:262-70. 2012
    ..The aim of this study was to gain further insight in the origin and characteristics of aberrant IELs by analysing T-cell receptor (TCR) rearrangements, and by immunophenotypic analysis of aberrant IELs...
  4. ncbi The spectrum of celiac disease: epidemiology, clinical aspects and treatment
    Greetje J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
    Nat Rev Gastroenterol Hepatol 7:204-13. 2010
    ..This complication is referred to as refractory celiac disease, and imposes a serious risk of developing a virtually lethal enteropathy-associated T-cell lymphoma...
  5. ncbi Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy
    G J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands
    Bone Marrow Transplant 46:840-6. 2011
    ..5 months. EATL was observed in one transplanted patient, only after 4 years of follow-up. Auto-SCT after conditioning with high-dose chemotherapy in RCD II patients unresponsive to cladribine therapy is feasible and seems promising...
  6. ncbi Evaluation of Cladribine treatment in refractory celiac disease type II
    Greetje J Tack
    Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands
    World J Gastroenterol 17:506-13. 2011
    ..To evaluate cladribine [2-chlorodeoxyadenosine (2-CdA)] therapy in refractory celiac disease (RCD) II...